Nancy Davidson - 07 Dec 2023 Form 4 Insider Report for Zymeworks Inc. (ZYME)

Role
Director
Signature
/s/ Daniel Dex, Attorney-in-Fact
Issuer symbol
ZYME
Transactions as of
07 Dec 2023
Transactions value $
$0
Form type
4
Filing time
08 Dec 2023, 17:18:46
Next filing
12 Dec 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZYME Stock Option (Right to Buy) Award $0 +74K $0.00 74K 07 Dec 2023 Common Stock 74K $9.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options vest in 36 equal monthly installments starting one month after grant date of December 7, 2023.